NCT01945879View on ClinicalTrials.gov

Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Pancreatic Cancer
Interventions
DRUG

Enoxaparine

al patients received additional low molecular heparin, if the safety cohort of three patients received at least 4 weeks of combined treatment without severe side effects, recruitment were continued until a minimum of 15 patients completed at least 3 months of treatment.

Trial Locations (1)

13353

Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

CONKO-Studiengruppe

OTHER

NCT01945879 - Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer | Biotech Hunter | Biotech Hunter